Novel Neurocognitive Screener Predicts Early/Delayed Post-CAR T Neurotoxicity: DCC Clinical Trial Discussion

Dr. Hill presents his research and conclusions on Novel Neurocognitive Screener Predicts Early/Delayed Post-CAR T Neurotoxicity and discusses specific Dartmouth Cancer Center clinical trials.

Presenter

John M. Hill, MD
Transplant and Cellular Therapy Program
Dartmouth Cancer Center

1. Identify early/delayed post-CAR T neurotoxicity through an enhanced neurologic assessment.
2. Describe potential donors for specific patients including the adverse effects associated with mismatched stem cell transplants.
3. Discuss the eligibility criteria and purpose of Donor Lymphocyte Infusions.

In support of improving patient care, Dartmouth Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

American Nurses Credentialing Center (ANCC)
Dartmouth Health designates this Enduring Material for a maximum of 0.75 ANCC contact hours.

Other Learners

All other learners may claim General Attendance credit. Consult your professional licensing board regarding the applicability and acceptance of General Attendance credit for programs certified for credit by organizations accredited by Joint Accreditation for Interprofessional Education.

Registration/Requirements for Successful Completion
You may claim credit for successful completion of this online course. In order to claim credit, you must follow these steps:

1. Click the Register tab above. If you are not logged into your account, you will need to log in. Use the Forgot Your Password? button if you need to reset your password.

2. Register for the activity.

3. Click the Content/Tests tab and then View Content to view the recording. View the entire presentation.

4. Complete the Post-Test (attestation - return to the Content/Tests tab to find it).

5. Click the Complete Evaluation button, or click My Account in the menu bar; then click Evaluations.

6. Complete and Submit the Evaluation.

Bibliographic Material

• Suresh, A., Wishart, H. A., Arslan, M., Hill, J. M., Jr. (2024). Novel neurocognitive testing tool for early neurotoxicity detection following anti-CD19 and anti-BCMA chimeric antigen receptor (CAR) T-cell therapy: A pilot study. Clinical Lymphoma, Myeloma and Leukemia, 25(6). https://doi.org/10.1016/j.clml.2024.12.011

Provider Contact Information

Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
ACE Office
Dartmouth Health
[email protected]

Mitigation of Relevant Financial Relationships

Dartmouth Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.  Any individuals in a position to control the content of a CE activity, including planners, faculty, authors, or others are required to disclose all financial relationships with ineligible companies^.  All relevant financial relationships have been mitigated prior to the commencement of the activity.

^Ineligible Company is any entity whose primary business purpose is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.